The appearance of troglitazone, a potent insulin-sensitizing agent, marked a significant chapter in the control of type 2 diabetes. However, its discontinuation from the market due to serious hepatotoxicity spurred https://keziakroe584416.mpeblog.com/73340951/troglityzone-and-related-glitazones-a-relative-overview